Literature DB >> 14560061

Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity.

Marco Catani1, Massimo Piccirilli, Maria Concetta Geloso, Antonio Cherubini, Giancarlo Finali, Gianpiero Pelliccioli, Umberto Senin, Patrizia Mecocci.   

Abstract

The association of motor neuron disease (MND) with rapidly progressive aphasic dementia has been recognized as a distinct clinical syndrome within the group of frontotemporal dementias (FTDs). Although the clinical and neuropsychological features of this syndrome have been defined, a small number of post-mortem studies have been published with heterogeneous neuropathological findings. We performed cognitive, neuro-imaging and neuropathological studies on a 71-year-old male with rapidly progressive aphasic dementia and MND. We initially found a selective non-fluent aphasia associated with hypoperfusion of the left frontotemporal cortex. Proton magnetic resonance spectroscopy revealed an asymmetric change of brain metabolites, with greater changes in the left temporal lobe. The bulbar manifestations of MND occurred over the following 6 months, and the patient died of bronchopneumonia. The neuropathological examination revealed loss of neurons in the hypoglossal nucleus and anterior horns of the cervical spinal cord with microvacuolation and dot-like ubiquitin-positive deposits in the frontoparietotemporal cortex, but no changes suggestive of Alzheimer's, Pick's or Lewy body disease. These findings support the conclusion that MND with rapidly progressive aphasic dementia is a distinctive clinical entity within the group of FTD-MND. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14560061     DOI: 10.1159/000074139

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

Review 1.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

2.  Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.

Authors:  Julie S Snowden; Sara Rollinson; Jennifer C Thompson; Jennifer M Harris; Cheryl L Stopford; Anna M T Richardson; Matthew Jones; Alex Gerhard; Yvonne S Davidson; Andrew Robinson; Linda Gibbons; Quan Hu; Daniel DuPlessis; David Neary; David M A Mann; Stuart M Pickering-Brown
Journal:  Brain       Date:  2012-02-02       Impact factor: 13.501

Review 3.  The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.

Authors:  Tim Van Langenhove; Julie van der Zee; Christine Van Broeckhoven
Journal:  Ann Med       Date:  2012-03-16       Impact factor: 4.709

4.  Syntactic processing as a marker for cognitive impairment in amyotrophic lateral sclerosis.

Authors:  Stella Tsermentseli; P Nigel Leigh; Lorna J Taylor; Aleksandar Radunovic; Marco Catani; Laura H Goldstein
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-24       Impact factor: 4.092

5.  Injury of the arcuate fasciculus in a patient with progressive bulbar palsy.

Authors:  Min Cheol Chang; Han Do Lee; Sung Ho Jang
Journal:  Neural Regen Res       Date:  2016-12       Impact factor: 5.135

Review 6.  Primary progressive aphasia and motor neuron disease: A review.

Authors:  Edoardo Nicolò Aiello; Sarah Feroldi; Giulia De Luca; Lucilla Guidotti; Eleonora Arrigoni; Ildebrando Appollonio; Federica Solca; Laura Carelli; Barbara Poletti; Federico Verde; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-09-08       Impact factor: 5.702

7.  ALS and Frontotemporal Dysfunction: A Review.

Authors:  Eugene Y Achi; Stacy A Rudnicki
Journal:  Neurol Res Int       Date:  2012-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.